AMPA receptor positive allosteric modulator: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
 
Line 35: Line 35:
[[Category:Neuropharmacology]]
[[Category:Neuropharmacology]]
[[Category:Receptor modulators]]
[[Category:Receptor modulators]]
== AMPA_receptor_positive_allosteric_modulator ==
<gallery>
File:CX-516-2D-skeletal.svg|CX-516 2D skeletal structure
File:Tulrampator_skeletal.svg|Tulrampator skeletal structure
</gallery>

Latest revision as of 01:31, 18 February 2025

AMPA receptor positive allosteric modulator

Chemical structure of CX-516
Chemical structure of Tulrampator

An AMPA receptor positive allosteric modulator is a type of compound that enhances the activity of the AMPA receptor, a subtype of the ionotropic glutamate receptors in the central nervous system. These modulators bind to the receptor at a site distinct from the glutamate binding site, leading to an increase in the receptor's response to glutamate.

Mechanism of Action[edit]

AMPA receptor positive allosteric modulators work by binding to the allosteric site on the AMPA receptor. This binding induces a conformational change in the receptor, which increases its affinity for glutamate and/or prolongs the open state of the ion channel. As a result, there is an increase in the flow of sodium ions (Na_) and calcium ions (Ca__) into the neuron, leading to enhanced synaptic transmission and neuroplasticity.

Pharmacological Effects[edit]

The primary effect of AMPA receptor positive allosteric modulators is the potentiation of excitatory synaptic transmission. This can lead to improved cognitive function, enhanced memory, and increased alertness. These compounds are being investigated for their potential therapeutic effects in conditions such as Alzheimer's disease, schizophrenia, and depression.

Examples[edit]

Several compounds have been identified as AMPA receptor positive allosteric modulators, including:

  • CX-516: Also known as Ampalex, CX-516 is one of the first AMPA receptor modulators to be studied for its cognitive-enhancing effects.
  • Tulrampator: A more recent compound, Tulrampator has shown promise in preclinical studies for its potential to improve cognitive function.

Research and Development[edit]

Research into AMPA receptor positive allosteric modulators is ongoing, with a focus on developing compounds with improved efficacy and safety profiles. Challenges include minimizing potential side effects such as excitotoxicity and seizures, which can result from excessive activation of glutamate receptors.

Related pages[edit]

Gallery[edit]

AMPA_receptor_positive_allosteric_modulator[edit]